naxcel
zoetis belgium sa - ceftiofur - antibacteriene pentru uz sistemic - pigs; cattle - pigstreatment of bacterial respiratory disease associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis and streptococcus suis. tratamentul septicemiei, poliartritei sau poliserozitei asociate cu infecția cu streptococcus suis. cattletreatment of acute interdigital necrobacillosis in cattle also known as panaritium or foot rot. tratamentul metritei acute post-partum (puerperală) la bovine, în cazurile în care tratamentul cu alt antimicrobian a eșuat.
neocolipor
boehringer ingelheim vetmedica gmbh - e. coli adhesin f4 (f4ab, f4ac, f4ad), e. coli adhesin f5, e. coli adhesin f6, e. coli adhesin f41 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - sows; sows (nullipar) - reducerea enterotoxicozei neonatale a purceilor, cauzată de e. coli, exprimând adezivii f4ab, f4ac, f4ad, f5, f6 și f41, în primele zile de viață.
enteroporc coli
ceva santé animale - inactivated fimbrial adhesins of escherichia coli f4ab, inactivated fimbrial adhesins of escherichia coli f4ac, inactivated fimbrial adhesins of escherichia coli f5, inactivated fimbrial adhesins of escherichia coli f6 - imunologii pentru suidae - porci - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6.
enteroporc coli ac
ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - porci - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:- clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6- clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins- clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.
softigyn min. 100.000.000 ufc
catalent italy s.p.a. - italia - diverse-lactobacillus - caps. moi vag. - antiinfectioase (excl. combinatii cu corticosteroizi) alte antiinfectioase si antiseptice
softigyn min. 100.000.000 ufc
catalent italy s.p.a. - italia - diverse-lactobacillus - caps. vag. - antiinfectioase (excl. combinatii cu corticosteroizi) alte antiinfectioase si antiseptice
floroprim 10^8 ufc + 10^6 ufc ovule
farmaprim srl - lactobacillus acidophilus + bifidobacterium bifidum - ovule - 10^8 ufc + 10^6 ufc
lacidofil -wm 2x10^9 cfu capsule
world medicine limited - lactobacillus rhamnosus + lactobacillus acidophilus - capsule - 2x10^9 cfu
linex forte capsule 2x10^9 cfu
lek pharmaceuticals d.d./ljubljana - lactobacillus acidophilus + bifidobacterium animal subsp. lapte - capsule - 2x10^9 cfu
bioselac capsule vaginale
rotapharm limited - lactobacillius rhamnosus 573 - capsule vaginale